FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024551508> ?p ?o ?g. }

• W2024551508 endingPage "518" @default.
• W2024551508 startingPage "509" @default.
• W2024551508 abstract "The aim of this study was to develop a discrete-time simulation model for people with type 1 diabetes mellitus, to estimate and compare mean life expectancy and quality-adjusted life-years (QALYs) over a lifetime between intensive and conventional blood glucose treatment groups.We synthesized evidence on type 1 diabetes patients using several published sources. The simulation model was based on 13 equations to estimate risks of events and mortality. Cardiovascular disease (CVD) risk was obtained from results of the DCCT (diabetes control and complications trial). Mortality post-CVD event was based on a study using linked administrative data on people with diabetes from Western Australia. Information on incidence of renal disease and the progression to CVD was obtained from studies in Finland and Italy. Lower-extremity amputation (LEA) risk was based on the type 1 diabetes Swedish inpatient registry, and the risk of blindness was obtained from results of a German-based study. Where diabetes-specific data were unavailable, information from other populations was used. We examine the degree and source of parameter uncertainty and illustrate an application of the model in estimating lifetime outcomes of using intensive and conventional treatments for blood glucose control.From 15 years of age, male and female patients had an estimated life expectancy of 47.2 (95 % CI 35.2-59.2) and 52.7 (95 % CI 41.7-63.6) years in the intensive treatment group. The model produced estimates of the lifetime benefits of intensive treatment for blood glucose from the DCCT of 4.0 (95 % CI 1.2-6.8) QALYs for women and 4.6 (95 % CI 2.7-6.9) QALYs for men. Absolute risk per 1,000 person-years for fatal CVD events was simulated to be 1.37 and 2.51 in intensive and conventional treatment groups, respectively.The model incorporates diabetic complications risk data from a type 1 diabetes population and synthesizes other type 1-specific data to estimate long-term outcomes of CVD, end-stage renal disease, LEA and risk of blindness, along with life expectancy and QALYs. External validation was carried out using life expectancy and absolute risk for fatal CVD events. Because of the flexible and transparent nature of the model, it has many potential future applications." @default.
• W2024551508 created "2016-06-24" @default.
• W2024551508 creator A5023996319 @default.
• W2024551508 creator A5024848912 @default.
• W2024551508 creator A5025231262 @default.
• W2024551508 creator A5051860736 @default.
• W2024551508 creator A5060924502 @default.
• W2024551508 date "2013-04-13" @default.
• W2024551508 modified "2023-10-17" @default.
• W2024551508 title "Simulating Lifetime Outcomes Associated with Complications for People with Type 1 Diabetes" @default.
• W2024551508 cites W1521343790 @default.
• W2024551508 cites W1545399534 @default.
• W2024551508 cites W1593493925 @default.
• W2024551508 cites W1752045965 @default.
• W2024551508 cites W1967540389 @default.
• W2024551508 cites W1980994260 @default.
• W2024551508 cites W1982991932 @default.
• W2024551508 cites W1985123503 @default.
• W2024551508 cites W1990283992 @default.
• W2024551508 cites W2000001040 @default.
• W2024551508 cites W2012838944 @default.
• W2024551508 cites W2018517254 @default.
• W2024551508 cites W2037345698 @default.
• W2024551508 cites W2056526409 @default.
• W2024551508 cites W2088095316 @default.
• W2024551508 cites W2094074260 @default.
• W2024551508 cites W2097150236 @default.
• W2024551508 cites W2098959597 @default.
• W2024551508 cites W2117796169 @default.
• W2024551508 cites W2120707871 @default.
• W2024551508 cites W2126252058 @default.
• W2024551508 cites W2134259348 @default.
• W2024551508 cites W2166904705 @default.
• W2024551508 cites W2169355652 @default.
• W2024551508 cites W2198678228 @default.
• W2024551508 cites W2520696266 @default.
• W2024551508 cites W2734011609 @default.
• W2024551508 cites W2769264260 @default.
• W2024551508 cites W4213289640 @default.
• W2024551508 cites W4256127771 @default.
• W2024551508 doi "https://doi.org/10.1007/s40273-013-0047-4" @default.
• W2024551508 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23585309" @default.
• W2024551508 hasPublicationYear "2013" @default.
• W2024551508 type Work @default.
• W2024551508 sameAs 2024551508 @default.
• W2024551508 citedByCount "11" @default.
• W2024551508 countsByYear W20245515082014 @default.
• W2024551508 countsByYear W20245515082015 @default.
• W2024551508 countsByYear W20245515082016 @default.
• W2024551508 countsByYear W20245515082018 @default.
• W2024551508 countsByYear W20245515082020 @default.
• W2024551508 countsByYear W20245515082021 @default.
• W2024551508 countsByYear W20245515082022 @default.
• W2024551508 crossrefType "journal-article" @default.
• W2024551508 hasAuthorship W2024551508A5023996319 @default.
• W2024551508 hasAuthorship W2024551508A5024848912 @default.
• W2024551508 hasAuthorship W2024551508A5025231262 @default.
• W2024551508 hasAuthorship W2024551508A5051860736 @default.
• W2024551508 hasAuthorship W2024551508A5060924502 @default.
• W2024551508 hasBestOaLocation W20245515082 @default.
• W2024551508 hasConcept C120665830 @default.
• W2024551508 hasConcept C121332964 @default.
• W2024551508 hasConcept C126322002 @default.
• W2024551508 hasConcept C133925201 @default.
• W2024551508 hasConcept C134018914 @default.
• W2024551508 hasConcept C177713679 @default.
• W2024551508 hasConcept C194828623 @default.
• W2024551508 hasConcept C2777180221 @default.
• W2024551508 hasConcept C2779134260 @default.
• W2024551508 hasConcept C2908647359 @default.
• W2024551508 hasConcept C555293320 @default.
• W2024551508 hasConcept C61511704 @default.
• W2024551508 hasConcept C71924100 @default.
• W2024551508 hasConcept C99454951 @default.
• W2024551508 hasConceptScore W2024551508C120665830 @default.
• W2024551508 hasConceptScore W2024551508C121332964 @default.
• W2024551508 hasConceptScore W2024551508C126322002 @default.
• W2024551508 hasConceptScore W2024551508C133925201 @default.
• W2024551508 hasConceptScore W2024551508C134018914 @default.
• W2024551508 hasConceptScore W2024551508C177713679 @default.
• W2024551508 hasConceptScore W2024551508C194828623 @default.
• W2024551508 hasConceptScore W2024551508C2777180221 @default.
• W2024551508 hasConceptScore W2024551508C2779134260 @default.
• W2024551508 hasConceptScore W2024551508C2908647359 @default.
• W2024551508 hasConceptScore W2024551508C555293320 @default.
• W2024551508 hasConceptScore W2024551508C61511704 @default.
• W2024551508 hasConceptScore W2024551508C71924100 @default.
• W2024551508 hasConceptScore W2024551508C99454951 @default.
• W2024551508 hasIssue "6" @default.
• W2024551508 hasLocation W20245515081 @default.
• W2024551508 hasLocation W20245515082 @default.
• W2024551508 hasLocation W20245515083 @default.
• W2024551508 hasOpenAccess W2024551508 @default.
• W2024551508 hasPrimaryLocation W20245515081 @default.
• W2024551508 hasRelatedWork W1563850031 @default.
• W2024551508 hasRelatedWork W2001756313 @default.
• W2024551508 hasRelatedWork W2233866314 @default.
• W2024551508 hasRelatedWork W2275480158 @default.

• next